SanBio Co Stock

SanBio Co Debt

The Debt of SanBio Co (4592.T) as of Aug 11, 2026 is -2.52 B JPY. In the previous year, Debt was -3.79 B JPY — a change of -33.39% (higher).

Debt

-2.52 BJPY

YoY

-33.39%

Last updated:

In 2026, SanBio Co's total debt was -2.52 B JPY, a -33.39% change from the -3.79 B JPY total debt recorded in the previous year.

Access this data via the Eulerpool API

SanBio Co Stock analysis

What does SanBio Co do? SanBio Co Ltd is a leading bio-pharmaceutical company focused on the development of products for the treatment of serious neurological diseases. The company was founded in Japan in 2000 and has since become a multinational company with offices in the USA and Europe. Answer: SanBio Co Ltd is a bio-pharmaceutical company that specializes in developing products for the treatment of serious neurological diseases. It was founded in Japan in 2000 and has expanded to become a multinational company with offices in the USA and Europe. SanBio Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding SanBio Co's Debt Structure

SanBio Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing SanBio Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to SanBio Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in SanBio Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about SanBio Co stock

Debt of SanBio Co is -2.52 B JPY in 2026.

Debt of SanBio Co changed from -3.79 B JPY to -2.52 B JPY, representing a -33.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt SanBio Co since 2006 – with annual values, charts, and detailed analysis.

Debt's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's SanBio Co historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — SanBio Co

All Key Metrics — SanBio Co